<p>Tinnitus is a common and often debilitating condition that substantially affects quality of life. While diabetes has been suggested as a potential risk factor, the relationship remains poorly understood, particularly in large population-based settings where classification of diabetes type often relies on algorithms rather than confirmatory biomarkers. The recent UK Biobank study by Ji and colleagues addresses this gap by reporting that type 2 diabetes is associated with higher tinnitus prevalence. While the study benefits from a large sample and systematic examination of diabetes-related factors, two methodological concerns warrant consideration before the findings are interpreted as robust evidence. First, diabetes type was determined using algorithmic classification without confirmatory biomarkers such as autoantibodies or C-peptide. Second, the analytical strategy treated age as a simple covariate, implicitly assuming that the diabetes–tinnitus association remains constant across the entire 40–70 year age range. While the study offers valuable hypothesis-generating data, these methodological considerations suggest that the reported associations should be interpreted cautiously until confirmed by biomarker-validated phenotyping and more flexible analytical approaches that account for age-related heterogeneity.</p>